Arrowhead Pharmaceuticals (ARWR) Other Non Operating Income (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) recorded Other Non Operating Income of $1.29 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$176,000 a year earlier.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Other Non Operating Income (2010 - 2026) Analysis & Trends
On a TTM basis, Arrowhead Pharmaceuticals' Other Non Operating Income came in at $4.61 million as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it came in at $5.26 million.
- Across earlier fiscal years, Other Non Operating Income came in at -$1.75 million in FY2024, $1.54 million in FY2023 (+101.0%), $765,000 in FY2022 (-63.0%) and $2.07 million in FY2021.
- Quarterly Other Non Operating Income has ranged from -$3.12 million in fiscal Q4 2024 to $4.66 million in fiscal Q4 2025 over the past five years.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 696.7% in fiscal Q4 2023, against a decline of 99.5% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.61 million (Q2 2026), $277,000 (Q1 2026) and $4.66 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | -176,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 341,000.00 |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | 760,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 421,000.00 |
| Sep 30, 2023 | 717,000.00 |
| Jun 30, 2023 | 306,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 507,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | -377,000.00 |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | -707,000.00 |
| Sep 30, 2021 | 363,000.00 |
API Access
Arrowhead Pharmaceuticals Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();